Cara Therapeutics Inc. | Ownership
Companies that own Cara Therapeutics Inc.
BlackRock Fund Advisors
2,091,071
5.32%
59,173
0%
06/30/2018
SSgA Funds Management, Inc.
1,720,096
4.38%
-901,501
0%
06/30/2018
The Vanguard Group, Inc.
1,193,785
3.04%
11,551
0%
06/30/2018
Chescapmanager LLC
1,164,431
2.96%
111,498
3.83%
06/30/2018
Disciplined Growth Investors, Inc.
858,287
2.18%
-1,278
0.3%
06/30/2018
Fidelity Management & Research Co.
691,735
1.76%
0
0%
06/30/2018
Carmignac Gestion SA
604,272
1.54%
604,272
0.06%
06/30/2018
Carmignac Gestion Luxembourg SA (UK)
604,272
1.54%
604,272
0.8%
06/29/2018
First Manhattan Co.
557,000
1.42%
374,900
0.06%
06/30/2018
T. Rowe Price Associates, Inc.
472,136
1.2%
-7,139
0%
06/30/2018
| Address |
4 Stamford Plaza
Stamford Connecticut 06902
United States
|
|
Employees
|
- |
| Website |
http://www.caratherapeutics.com |
| Updated |
07/08/2019 |
| CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. |
